Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the presence of DPA or its metabolites has never been documented in the skin, because of inherent difficulties in determining its tissue levels. Thus, the association between DPA and DPA-related dermatoses has been only hypothesized on the basis of careful history, clinical observation and typical histopathological findings
Introduction: We describe an interesting patient with penicillamine-induced dermopathy. Clinical Pic...
Penicillamine toxicity in Wilson’s disease has been well reported but rarely seen now as newer agent...
A 47 year old man presented with a two year history of increasing cervical dysphagia, dyspnoea, and ...
Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the...
Long term D-penicillamine (DPA) therapy to treat Wilson disease can induce elastosis perforans serpi...
Elastosis perforans serpiginosa (EPS) is a rare complication of chronic therapy with a high-dose of ...
Long term use of D-penicillamine for Wilson’s disease can be associated with many adverse reactions ...
Elastosis perforans serpiginosa (EPS) is an unusual perforating disorder characterized by extrusion ...
Long term D-penicillamine therapy, especially when used to treat Wilson′s disease has been shown to...
AbstractElastosis perforans serpiginosa (EPS) is an unusual perforating disorder characterized by ex...
Four types of elastosis perforans serpiginosa (EPS) have been described in literature: 1) idiopathic...
Penicillamine-induced skin changes are rare and include: hypersensitivity reactions, autoimmune reac...
Skin biopsies from 4 systemic sclerosis (SSc) patients, 6 SSc patients treated with D-penicillamine ...
Several drugs have been suggested to cause lupus-like syndrome. However, penicillamine-induced lupus...
D-Penicillamine is one of the diseases modifying medication used to treat Rheumatoid arthritis and S...
Introduction: We describe an interesting patient with penicillamine-induced dermopathy. Clinical Pic...
Penicillamine toxicity in Wilson’s disease has been well reported but rarely seen now as newer agent...
A 47 year old man presented with a two year history of increasing cervical dysphagia, dyspnoea, and ...
Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the...
Long term D-penicillamine (DPA) therapy to treat Wilson disease can induce elastosis perforans serpi...
Elastosis perforans serpiginosa (EPS) is a rare complication of chronic therapy with a high-dose of ...
Long term use of D-penicillamine for Wilson’s disease can be associated with many adverse reactions ...
Elastosis perforans serpiginosa (EPS) is an unusual perforating disorder characterized by extrusion ...
Long term D-penicillamine therapy, especially when used to treat Wilson′s disease has been shown to...
AbstractElastosis perforans serpiginosa (EPS) is an unusual perforating disorder characterized by ex...
Four types of elastosis perforans serpiginosa (EPS) have been described in literature: 1) idiopathic...
Penicillamine-induced skin changes are rare and include: hypersensitivity reactions, autoimmune reac...
Skin biopsies from 4 systemic sclerosis (SSc) patients, 6 SSc patients treated with D-penicillamine ...
Several drugs have been suggested to cause lupus-like syndrome. However, penicillamine-induced lupus...
D-Penicillamine is one of the diseases modifying medication used to treat Rheumatoid arthritis and S...
Introduction: We describe an interesting patient with penicillamine-induced dermopathy. Clinical Pic...
Penicillamine toxicity in Wilson’s disease has been well reported but rarely seen now as newer agent...
A 47 year old man presented with a two year history of increasing cervical dysphagia, dyspnoea, and ...